Print
Email
Print Edition Stories
Breaking down the MIT $100K
MHT's Marc Songini: Technology to keep seniors healthy
MHT's Doug Banks: 10 Women to Watch in tech
A Boston-area technology transfer company hopes to help a university spinout bring to market a treatment for tinnitus, a ringing in the ears that affects nearly one in five people, and is the number-one disability for U.S. troops returning from combat, according to a recent study by the U.S. Department of Veterans’ Affairs.
SoundCure Inc. aims to commercialize an acoustic therapy developed by researchers at the University of California at Irvine.
The company, which will be based in California, is backed by a partnership between UC Irvine and Allied Minds Inc., a Quincy-based seed investment corporation specializing in early-stage university business ventures.
The technology would replace therapies involving long retraining regimes or drug treatments that carry side effects, according to a press release issued today. The SoundCure treatment uses customized sound frequencies and pulsed tones designed to counter the effects of tinnitus, and is shown to provide long-term suppression of the syndrome, the press release stated.
“There’s really not a good way to deal with it,” said Chris Silva, CEO at Allied Minds.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
